Skip to main content
. 2020 Dec 1;15(12):e0243077. doi: 10.1371/journal.pone.0243077

Table 3. Fungal genera exhibiting significant differential abundance (BH corrected P ≤0.05) between the gut mycobiomes of Healthy controls (HC, n = 30) and Diabetes Mellitus (T2DM, n = 21) individuals.

S. No. Genus Median Abundance (%)* Wilcoxon test—P value (BH corrected P value ≤ 0.05) Pathogenicity
HC T2DM
Genera decreased in T2DM
1 Issatchenkia 2.387 0.093 0 Plant/Human pathogen
2 Macrophomina 0.616 0 0 Plant pathogen
3 Marasmius 0.451 0.215 0 Commensal
4 Gymnopilus 0.308 0.123 0.043 Commensal
5 Saccharomyces 0.261 0.127 0 Non pathogen
6 Trichoderma 0.134 0.05 0.043 Plant pathogen
7 Cochliobolus 0.114 0 0 Plant pathogen
8 Psathyrella 0.102 0.031 0.043 Commensal
9 Clavispora 0.027 0.001 0 Not known
10 Didymella 0.011 0.002 0 Plant pathogen
11 Ganoderma 0.007 0 0.043 Plant pathogen
12 Rhizopus 0.006 0 0 Plant/Human pathogen
13 Mycosphaerella 0.005 0.003 0.043 Plant pathogen
14 Wickerhamomyces 0.005 0 0 Antimicrobial
15 Gliocladiopsis 0.004 0 0 Plant pathogen
16 Cuphophyllus 0.002 0 0 Commensal
17 Cylindrocladiella 0.002 0 0 Plant pathogen
18 Backusella 0.001 0 0 Not known
19 Corynespora 0.001 0 0 Plant pathogen
20 Vishniacozyma 0.001 0 0.043 Antimicrobial
21 Volutella 0.001 0 0.043 Plant pathogen
Genera increased in T2DM
1 Candida 0.878 8.119 0 Human pathogen
2 Cladosporium 0.023 0.658 0 Plant pathogen
3 Kodamaea 0.001 0.014 0.043 Human pathogen
4 Meyerozyma 0.001 0.067 0 Human pathogen
5 Mortierella 0 0.187 0 Soil fungi

*Differentially abundant genera having a median abundance ≥ 0.001% in at least one group of samples are listed.

P value of 0 indicates ≤ 0.0001.